199 related articles for article (PubMed ID: 17162625)
1. Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.
Phillips KA; Pagano ME; Menard W
Ann Clin Psychiatry; 2006; 18(4):251-7. PubMed ID: 17162625
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
[TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders.
Phillips KA; Pinto A; Menard W; Eisen JL; Mancebo M; Rasmussen SA
Depress Anxiety; 2007; 24(6):399-409. PubMed ID: 17041935
[TBL] [Abstract][Full Text] [Related]
4. Insight in obsessive compulsive disorder and body dysmorphic disorder.
Eisen JL; Phillips KA; Coles ME; Rasmussen SA
Compr Psychiatry; 2004; 45(1):10-5. PubMed ID: 14671731
[TBL] [Abstract][Full Text] [Related]
5. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.
Phillips KA; McElroy SL; Dwight MM; Eisen JL; Rasmussen SA
J Clin Psychiatry; 2001 Feb; 62(2):87-91. PubMed ID: 11247107
[TBL] [Abstract][Full Text] [Related]
6. Body dysmorphic disorder.
Allen A; Hollander E
Psychiatr Clin North Am; 2000 Sep; 23(3):617-28. PubMed ID: 10986731
[TBL] [Abstract][Full Text] [Related]
7. Body dysmorphic disorder: diagnostic controversies and treatment challenges.
Phillips KA
Bull Menninger Clin; 2000; 64(1):18-35. PubMed ID: 10695157
[TBL] [Abstract][Full Text] [Related]
8. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.
Phillips KA; Hollander E
Body Image; 2008 Mar; 5(1):13-27. PubMed ID: 18325859
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
Phillips KA; Albertini RS; Siniscalchi JM; Khan A; Robinson M
J Clin Psychiatry; 2001 Sep; 62(9):721-7. PubMed ID: 11681769
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fluvoxamine in body dysmorphic disorder.
Phillips KA; Dwight MM; McElroy SL
J Clin Psychiatry; 1998 Apr; 59(4):165-71. PubMed ID: 9590666
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of body dysmorphic disorder in adolescents.
Hadley SJ; Greenberg J; Hollander E
Curr Psychiatry Rep; 2002 Apr; 4(2):108-13. PubMed ID: 11914171
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in body dysmorphic disorder.
Carroll DH; Scahill L; Phillips KA
Arch Psychiatr Nurs; 2002 Apr; 16(2):72-9. PubMed ID: 11925574
[TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive disorder and body dysmorphic disorder: a comparison of clinical features.
Frare F; Perugi G; Ruffolo G; Toni C
Eur Psychiatry; 2004 Aug; 19(5):292-8. PubMed ID: 15276662
[TBL] [Abstract][Full Text] [Related]
14. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
Nakamae T
Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
[TBL] [Abstract][Full Text] [Related]
15. Recognizing and treating body dysmorphic disorder.
Grant JE; Phillips KA
Ann Clin Psychiatry; 2005; 17(4):205-10. PubMed ID: 16402752
[TBL] [Abstract][Full Text] [Related]
16. Body dysmorphic disorder: treating an underrecognized disorder.
Phillips KA; Didie ER; Feusner J; Wilhelm S
Am J Psychiatry; 2008 Sep; 165(9):1111-8. PubMed ID: 18765493
[TBL] [Abstract][Full Text] [Related]
17. Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia.
Phillips KA; Stout RL
J Psychiatr Res; 2006 Jun; 40(4):360-9. PubMed ID: 16309706
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity of body dysmorphic disorder and eating disorders: severity of psychopathology and body image disturbance.
Ruffolo JS; Phillips KA; Menard W; Fay C; Weisberg RB
Int J Eat Disord; 2006 Jan; 39(1):11-9. PubMed ID: 16254870
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
20. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
Phillips KA; Albertini RS; Rasmussen SA
Arch Gen Psychiatry; 2002 Apr; 59(4):381-8. PubMed ID: 11926939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
